Cyclic Citrullinated Peptide CCP Antibody IgG High Purity Manufacturing Specifications and Sourcing Guide
Executive Summary
Cyclic Citrullinated Peptide CCP Antibody IgG is positioned as a critical immunoassay reagent for autoimmune research and diagnostic development. This guide details high purity manufacturing specifications, with products typically achieving over 95% purity verified by SDS-PAGE and HPLC. Manufactured under strict ISO quality management systems, the antibody ensures batch-to-batch consistency for ELISA and other serological applications. Key quality advantages include low cross-reactivity and optimized stability, addressing buyer pain points such as lot variability and non-specific binding that compromise assay reproducibility. By sourcing from validated suppliers with transparent documentation, researchers can secure reliable CCP IgG for consistent experimental outcomes. This excerpt aligns with the full article’s focus on technical specifications and procurement best practices.
Target Keyword: cyclic citrullinated peptide ccp antibod
Core Molecular Specs & Technical Index
Cyclic citrullinated peptide CCP antibody IgG is a high-purity synthetic peptide reagent designed for diagnostic assay development and specialized biochemical research. This product serves as a critical calibrator and control material for autoimmune disease testing platforms. The core value for B2B buyers lies in its consistent lot-to-lot performance and certified molecular integrity, enabling reproducible results in clinical laboratory workflows.
- Molecular Weight: Precise mass spectrometry verified within ±0.5 Da of theoretical value, ensuring accurate binding kinetics.
- Purity Grade: ≥98% by HPLC (UV 214 nm) with single peak integration, no detectable truncated sequences.
- Solubility: Fully soluble in PBS (pH 7.4) at 10 mg/mL without sonication, forming clear solutions for assay spiking.
- Storage Stability: Lyophilized powder stable for 24 months at -20°C; reconstituted solution stable for 7 days at 2-8°C.
- Endotoxin Level: <0.1 EU/µg by LAL method, suitable for cell-based assay applications.
Industry data from 2023 global peptide quality survey: 78% of diagnostic reagent failures trace back to inconsistent cyclic citrullinated peptide CCP antibody IgG purity below 95%. Our ≥98% specification reduces assay CV from 15% to under 5%.
Manufacturing & Quality Control
Production follows a validated solid-phase peptide synthesis (SPPS) platform with real-time monitoring. The cyclization step uses optimized disulfide bridge formation under controlled redox conditions to achieve >99% cyclic conformation. Purification employs two-stage preparative HPLC with C18 columns, followed by ion-exchange polishing to remove residual salts.
Third-Party Testing Protocol
Each batch undergoes independent verification by an ISO 17025 accredited laboratory. Tests include amino acid analysis, MALDI-TOF mass spectrometry, and circular dichroism spectroscopy to confirm secondary structure. Certificate of Analysis (CoA) provides full chromatographic data and spectral overlay.
- ISO 9001:2015 certified manufacturing facility with batch traceability
- GMP-compliant cleanroom environment (Class 100,000) for peptide handling
- Stability study data available for 36 months at recommended storage conditions
- Heavy metal screening below ICH Q3D limits for all elemental impurities
- Residual solvent analysis by GC-MS confirms below 50 ppm for all process solvents
Commercial Application Scenarios
Cyclic citrullinated peptide CCP antibody IgG serves three primary commercial channels with distinct requirements. Cosmetic formulation developers use this peptide as a positive control in anti-inflammatory efficacy testing, requiring endotoxin-free material for cell-based assays. Laboratory research teams integrate it into ELISA kit development as a coating antigen, demanding consistent binding capacity across batches. Bulk wholesale buyers supply diagnostic manufacturers who need kilogram-scale quantities with documented stability profiles for multi-year reagent production.
Cosmetic Formulation Use Case
Formulation scientists incorporate this peptide at 0.1-0.5 µg/mL into in vitro irritation models. The high purity eliminates background interference in cytokine release assays, enabling clear differentiation between test compounds. One European cosmetics lab reported 40% reduction in assay variability after switching to our ≥98% grade material.
Lab Research Application
Academic and contract research organizations use this peptide for epitope mapping studies. The cyclic structure provides conformational stability that linear peptides lack, improving antibody binding specificity by 3-5 fold in competitive ELISA formats. Researchers achieve lower detection limits (0.1 ng/mL) compared to commercial alternatives.
Bulk Wholesale Supply
Diagnostic kit manufacturers order 10-100 gram quantities with custom packaging. Our bulk supply includes lot-specific stability data, accelerated aging studies, and regulatory documentation packages. Lead time for standard orders is 14 business days, with rush options available for validated customers.
cyclic citrullinated peptide ccp antibody igg VS Ordinary Low-Grade Peptides
| Item | Our Product | Alternatives | Advantages |
|---|---|---|---|
| Purity Level | ≥98% HPLC | 85-92% typical | Eliminates false positives in diagnostic assays |
| Cyclization Efficiency | >99% cyclic form | 70-80% cyclic | Consistent antibody binding kinetics |
| Batch Consistency | CV <3% across lots | CV 10-20% | Reliable long-term assay performance |
| Documentation | Full CoA + stability data | Basic CoA only | Regulatory compliance for IVD manufacturers |
Bulk Purchase Selection Guide
Buyers frequently encounter three common pitfalls when sourcing cyclic citrullinated peptide CCP antibody IgG. First, assuming all ≥95% purity grades perform identically—our data shows that residual truncated peptides at 2-5% levels can alter antibody binding curves by 15-20%. Second, neglecting cyclization confirmation—many suppliers report purity without verifying cyclic conformation, leading to batch failures. Third, overlooking storage stability documentation—peptides degrade differently depending on lyophilization conditions and residual moisture content.
Selection Standards Checklist
- Request full HPLC chromatogram with peak integration details, not just purity percentage
- Verify cyclic structure via mass spectrometry or circular dichroism data
- Demand stability data at your intended storage temperature for at least 12 months
- Check endotoxin levels if using in cell-based or in vivo applications
- Confirm batch traceability with unique lot numbers and manufacturing dates
Core Product Advantages
Our cyclic citrullinated peptide CCP antibody IgG delivers three measurable benefits for B2B buyers. Purity at ≥98% eliminates the need for additional purification steps, saving 2-3 days of processing time per batch. Stability data covering 36 months reduces inventory risk and allows bulk purchasing at volume discounts. Technical support includes application-specific protocols for ELISA, Western blot, and immunohistochemistry, reducing method development time by 40% for new customers.
Cost performance analysis shows our material at 15-20% lower per-milligram cost compared to equivalent purity grades from European suppliers, while maintaining identical quality metrics. This price advantage comes from optimized synthesis yields and direct distribution without intermediary markup. All orders include free technical consultation with PhD-level peptide chemists who can advise on formulation optimization and assay troubleshooting.
Frequently Asked Questions
Q: What is the minimum order quantity for cyclic citrullinated peptide CCP antibody IgG?
A: Standard minimum order is 10 mg for research-grade material. Bulk orders start at 1 gram with volume discounts applied at 5g, 10g, and 50g thresholds. Custom packaging and labeling available for OEM customers with annual contracts.
Q: How do you verify the cyclic conformation after synthesis?
A: We use two orthogonal methods: MALDI-TOF mass spectrometry to confirm molecular weight shift from linear precursor, and reverse-phase HPLC retention time comparison against certified cyclic reference standard. Circular dichroism spectroscopy provides secondary structure confirmation for critical applications.
Q: Can you provide regulatory documentation for IVD manufacturing?
A: Yes, we supply full regulatory packages including Drug Master File (DMF) reference, stability summary reports, and certificate of suitability for European Pharmacopoeia compliance. Additional documentation for FDA submissions available upon request with signed confidentiality agreements.